Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis. Novakova L, Axelsson M, Malmeström C, Zetterberg H, Björkhem I, Karrenbauer V D, Lycke J J Neurol Sci. 2015 Aug 29. PMID: 26342940. Abstract CommentRecommendBookmarkWatch